Personality, Addiction, Dopamine: Insights from Parkinson's Disease

被引:265
|
作者
Dagher, Alain [1 ]
Robbins, Trevor W. [2 ,3 ]
机构
[1] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada
[2] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England
[3] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
IMPULSE CONTROL DISORDERS; NUCLEUS-ACCUMBENS DOPAMINE; GOAL-DIRECTED BEHAVIOR; REWARD-RELATED STIMULI; BASAL GANGLIA; D-3; RECEPTOR; FRONTOTEMPORAL DEMENTIA; INCENTIVE SALIENCE; DRUG-ADDICTION; MESENCEPHALIC DOPAMINE;
D O I
10.1016/j.neuron.2009.01.031
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In rare instances, patients with Parkinson's disease (PD) may become addicted to their own medication or develop behavioral addictions such as pathological gambling. This is surprising because PD patients typically have a very low incidence of drug abuse and display a personality type that is the polar opposite of the addictive personality. These rare addictive syndromes, which appear to result from excessive dopaminergic medication use, illustrate the link between dopamine, personality, and addiction. We describe the clinical phenomena and attempt to relate them to current models of learning and addiction. We conclude that persistently elevated dopaminergic stimulation promotes the development and maintenance of addictive behaviors.
引用
收藏
页码:502 / 510
页数:9
相关论文
共 50 条
  • [1] Personality, Dopamine, and Parkinson's Disease: Insights From Subthalamic Stimulation
    Lhommee, Eugenie
    Boyer, Francois
    Wack, Maxime
    Pelissier, Pierre
    Klinger, Helene
    Schmitt, Emmanuelle
    Bichon, Amelie
    Fraix, Valerie
    Chabardes, Stephan
    Mertens, Patrick
    Castrioto, Anna
    Kistner, Andrea
    Broussolle, Emmanuel
    Thobois, Stephane
    Krack, Paul
    MOVEMENT DISORDERS, 2017, 32 (08) : 1191 - 1200
  • [2] COMPULSIVE USE OF DOPAMINE REPLACEMENT THERAPY IN PARKINSON'S DISEASE: INSIGHTS INTO THE NEUROBIOLOGY OF ADDICTION
    Brown, Robyn M.
    Lawrence, Andrew J.
    ADDICTION, 2012, 107 (02) : 250 - 251
  • [3] Addiction to levodopa: Dopamine dysregulation syndrome in Parkinson's disease
    Pandey, S.
    Mehndiratta, M.
    MOVEMENT DISORDERS, 2012, 27 : S282 - S282
  • [4] Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease
    Merims, Doron
    Giladi, Nir
    PARKINSONISM & RELATED DISORDERS, 2008, 14 (04) : 273 - 280
  • [5] The role of dopamine in action control: Insights from medication effects in Parkinson's disease
    Ruitenberg, M. F. L.
    van Wouwe, N. C.
    Wylie, S. A.
    Abrahamse, E. L.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2021, 127 : 158 - 170
  • [6] The role of dopamine pharmacotherapy and addiction-like behaviors in Parkinson's disease
    Napier, T. Celeste
    Kirby, Alana
    Persons, Amanda L.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2020, 102
  • [7] Zona incerta: from Parkinson's disease to addiction
    Wilt, Mylene
    Magnard, Robin
    Carnicella, Sebastien
    Vachez, Yvan M.
    FRONTIERS IN NEURAL CIRCUITS, 2025, 19
  • [8] ADDICTION AS ABERRANT LEARNINGuEVIDENCE FROM PARKINSON'S DISEASE
    Soyka, Michael
    ADDICTION, 2012, 107 (02) : 248 - 248
  • [9] New insights into levodopa induced dopamine release in Parkinson's disease
    Sossi, Vesna
    Gonzalez, Marjorie
    Dinelle, Katherine
    Heffernan, Nicole
    McKenzie, Jess
    Appel-Cresswell, Silke
    McKeown, Martin
    Stoessl, A. Jon
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 : S141 - S141
  • [10] The degeneration of dopamine neurons in Parkinson's disease insights from embryology and evolution of the mesostriatocortical system
    Vernier, P
    Moret, F
    Callier, S
    Snapyan, M
    Wersinger, C
    Sidhu, A
    PROTECTIVE STRATEGIES FOR NEURODEGENERATIVE DISEASES, 2004, 1035 : 231 - 249